Human Papillomavirus Vaccine Types 16 and 18 (HPV2)
No
Yes
Subsidised Vaccine List
Active ingredients: Vaccine Papillomavirus | Papillomavirus Vaccine | Human Papillomavirus Vaccine Types 16 and 18 (HPV2)
General information
Subsidy Information and Financing Scheme
[SVL] Human Papillomavirus Vaccine Types 16 and 18 (HPV2) (Cervarix) Injection, Human Papillomavirus Vaccine (Recombinant) Type-16 20 micrograms/0.5 mL + Type-18 20 micrograms/0.5 mL
National Childhood Immunisation Schedule (NCIS), National Adult Immunisation Schedule (NAIS)
Drug Guidance for Subsidy
Not Applicable
General Availability in Public Healthcare Institution
Note:
General availability information reflected is based on the Public Healthcare Institutions’ (PHI) formulary on what is commonly used for treating their patient population and may or may not be available for patients not under the care of that institution. It does not reflect the PHI’s actual inventory availability and is subjected to change. Please consult the Public Hospitals or Polyclinics for details on availability and supply restrictions/considerations. General availability is not tied to any brand unless otherwise stated.
Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration
Availability information
Formulation | Public Healthcare Institution |
|---|---|
Cervarix Injection, Human Papillomavirus Vaccine (Recombinant) Type-16 20 micrograms/0.5 mL + Type-18 20 micrograms/0.5 mL |
|
List of monographs containing this active ingredient
Human Papillomavirus Vaccine Types 16 and 18 (HPV2) [Cervarix]
